Serina Therapeutics, Inc. (SER) NYSE

4.89

-0.26(-5.05%)

Updated at October 16 04:00PM

Currency In USD

Valuation

Market Cap36.87M
Enterprise Value33.46M
P/E Ratio-3.89
PEG Ratio0
Price/Sales Ratio385.58
Price/Book Ratio27.15
Enterprise/Revenue340.53
Enterprise/EBITDA-3.55

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-96.85
Operating Margin-171.42

Management Effectiveness

Return On Assets-1.41
Return On Equity5.23

Income Statement

Revenue56,000
Revenue/Share0.01
Gross Profit-138,000
EBITDA-10.49M
Net Income-11.14M
Diluted EPS-1.51

Balance Sheet

Total Cash6.04M
Total Cash/Share0.6
Total Debt185,000
Total Debt/Equity0.1
Current Ratio2.24
Book Value Per Share0.16

Price History

52-Week Change-35.32
52-Week High8.05
52-Week Low3.81
Moving Average 50 Days5.22
Moving Average 200 Days5.25

Statistics

Average Volume126,657
Shares Outstanding10.25M
% Held by Institutions4.13

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor7:250
Last Split DateMarch 15, 2024